With a passion for outsmarting relentless cancers and autoimmune diseases, Byondis takes precision medicines to the next level. We are driven by one goal: providing novel treatments with high efficacy and low systemic toxicity for patients with high unmet medical needs.

Many companies work in the areas of unmet need. What differentiates Byondis is its focus on producing a broad spectrum of molecular concepts, ranging from small molecule chemistries to complex protein structures. We engineer smaller and larger molecular functionalities that may be combined to target the right part of the body. This involves:
•	Next generation antibody-drug conjugates (ADCs), including proprietary linker-drug (LD) technology to generate multiple ADC candidates targeting different indications
•	Site-specific conjugation technology
•	Monoclonal antibodies (mAbs)
•	Highly selective, disease-targeting small molecules

The success of our company fully depends on our people. To them, we aim to provide a fair, open and inspiring working environment, where there is room for ambition, entrepreneurship and new initiatives leading to new medicines that save and transform patients’ lives.

Therapeutics

Biotechnology

Byondis

Byondis' headquarters in NIJMEGEN, Netherlands

This department focuses on the development and execution of bioassays and bioanalytical methods to support research and project initiatives.

Bioanalysis & Bioassay

This department focuses on conducting studies and experiments to advance knowledge and develop new products or solutions.

Research and Development

The Leadership Team at Byondis is responsible for steering the strategic direction and overall operations of the company. Comprised of top executives and principal scientists, the team ensures alignment between scientific innovation and business objectives. They drive initiatives to advance the company's precision medicine portfolio, oversee research and development, manage corporate development, and ensure legal and regulatory compliance, all to fulfill the company’s mission of providing novel, effective treatments for cancers and autoimmune diseases.

Leadership Team

The Scientific Research and Development team at Byondis is dedicated to advancing novel treatments for cancers and autoimmune diseases. This multidisciplinary team focuses on pioneering next-generation antibody-drug conjugates (ADCs), creating proprietary linker-drug (LD) technology, and developing site-specific conjugation methods. Their expertise extends to monoclonal antibodies (mAbs) and highly selective small molecules, ensuring precision in disease targeting. This team plays a pivotal role in translating molecular innovations into life-saving therapies with high efficacy and low systemic toxicity.

Scientific Research and Development

This department focuses on ensuring the quality and reliability of products through testing and validation processes.

Quality Assurance

This department focuses on conducting research and development related to in vitro pharmacological studies.

��

People (6)

Jobs (0)

Other teams

Research and Development

Leadership Team

Scientific Research and Development

Quality Assurance

In Vitro Pharmacology

��������

People (6)

Jobs (0)

Other teams

Research and Development

Leadership Team

Scientific Research and Development

Quality Assurance

In Vitro Pharmacology

��